Travis Rice's newest evolution of his Natural Selection Tour debuts this week with the highly anticipated surf event — and ...

If like us, you’re fantasising about shorts and sandals weather and keep finding yourself furiously Googling “when will it get lighter”, you’re no doubt ready to say farewell to your winter boots.

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and ...

Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...

I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and sneakers, as well as debunking wellness myths. On my spare time I enjoy ...

In its second pipeline-boosting deal in two days, Sanofi has pledged €469 million (around $490 million) upfront for rights to an anti-TL1A therapy being developed by Teva for inflammatory bowel ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

There are a LOT of running shoes on the market and each pair comes in all shapes and sizes offering all sorts of things from speed to agility to support to style. While it might be tempting to ...